WWHS BIOTECH

WWHS Biotech Inc. ("WWHS") is a holding subsidiary of Sansure Biotech Inc.

Focused on second near-infrared window (NIR-II) fluorescence enhancement technology, WWHS integrates R&D and manufacturing of reagents, instruments, and nanomaterials. Incubated by the Research Institute of Tsinghua University in Shenzhen, it is a National High-tech Enterprise (HNTE) and a Shenzhen's "Specialized, Refined, Differentiated and Innovative" (SRDI) small and medium-sized enterprises (SMEs), recipient of the "Outstanding Product Award" at the China Hi-Tech Fair and other honors, and certified to ISO 13485.

The company was among the first to apply NIR-II fluorescence technology to in vitro diagnostics (IVD), striving to make NIR-II precision testing widely accessible to all and bring frontier technology to broader primary-care settings.

Guided by its brand promise "Meticulous in every detail, devoted to every life," echoing Sansure's mission of Innovating Life Tech For All , WWHS will continue to harness the physical-level precision of NIR-II to ensure that every diagnosis that should not be constrained by circumstance receives an accurate answer.